Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Lecron

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Blood|May 1, 1988
Characterization of prothymocytes with cloning capacity in human bone marrowM D Mossalayi, J C Lecron, P Goube de Laforest, et al.
Leukemia & Lymphoma|July 1, 1994
Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23A Brizard, F Morel, J C Lecron, et al.
Biotechnology Therapeutics|January 1, 1994
Effects of alpha-interferon on MHC unrestricted cytotoxicity in chronic myelogenous leukemiaA Meseri-Delwail, V Delwail, A Brizard, et al.
Neuropeptides|April 3, 1999
An antagonistic monoclonal antibody (B-N6) specific for the human neurotensin receptor-1J M Ovigne, C Vermot-Desroches, J C Lecron, et al.
American Journal of Hematology|September 1, 1993
Effects of sCD23 on proliferation of leukemic cells from a patient with chronic myelogenous leukemia during blast crisisF Morel, V Delwail, A Brizard, et al.
Clinical Chemistry|June 6, 2000
Sensitive ELISA for human immunoglobulin D measurement in neonate, infant, and adult seraI Levan-Petit, J Cardonna, M Garcia, et al.
International Immunology|November 5, 1999
T(h)2 cytokine dependence of IgD production by normal human B cellsI Levan-Petit, E Lelievre, A Barra, et al.
Haematologica|December 7, 2007
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell diseaseF Noizat-Pirenne, D Bachir, P Chadebech, et al.
Experimental Hematology|May 1, 1990
In vitro differentiation and proliferation of purified human thymic and bone marrow CD7+CD2- T-cell precursorsM D Mossalayi, A H Dalloul, J M Bertho, et al.
Immunology Letters|October 1, 1996
Serum soluble CD23 levels in giant cell arteritisP Roblot, F Morel, E Lelièvre, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Blood|May 1, 1988
Characterization of prothymocytes with cloning capacity in human bone marrowM D Mossalayi, J C Lecron, P Goube de Laforest, et al.
Leukemia & Lymphoma|July 1, 1994
Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23A Brizard, F Morel, J C Lecron, et al.
Biotechnology Therapeutics|January 1, 1994
Effects of alpha-interferon on MHC unrestricted cytotoxicity in chronic myelogenous leukemiaA Meseri-Delwail, V Delwail, A Brizard, et al.
Neuropeptides|April 3, 1999
An antagonistic monoclonal antibody (B-N6) specific for the human neurotensin receptor-1J M Ovigne, C Vermot-Desroches, J C Lecron, et al.
American Journal of Hematology|September 1, 1993
Effects of sCD23 on proliferation of leukemic cells from a patient with chronic myelogenous leukemia during blast crisisF Morel, V Delwail, A Brizard, et al.
Clinical Chemistry|June 6, 2000
Sensitive ELISA for human immunoglobulin D measurement in neonate, infant, and adult seraI Levan-Petit, J Cardonna, M Garcia, et al.
International Immunology|November 5, 1999
T(h)2 cytokine dependence of IgD production by normal human B cellsI Levan-Petit, E Lelievre, A Barra, et al.
Haematologica|December 7, 2007
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell diseaseF Noizat-Pirenne, D Bachir, P Chadebech, et al.
Experimental Hematology|May 1, 1990
In vitro differentiation and proliferation of purified human thymic and bone marrow CD7+CD2- T-cell precursorsM D Mossalayi, A H Dalloul, J M Bertho, et al.
Immunology Letters|October 1, 1996
Serum soluble CD23 levels in giant cell arteritisP Roblot, F Morel, E Lelièvre, et al.
Pageof 6